- Home
- ACIU vs ANNA Comparison
ACIU vs ANNA Comparison
Compare ACIU & ANNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- ANNA
- Stock Information
- Founded
- ACIU 2003
- ANNA 2007
- Country
- ACIU Switzerland
- ANNA United States
- Employees
- ACIU N/A
- ANNA N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- ANNA
- Sector
- ACIU Health Care
- ANNA
- Exchange
- ACIU Nasdaq
- ANNA NYSE
- Market Cap
- ACIU 247.4M
- ANNA 230.0M
- IPO Year
- ACIU 2016
- ANNA N/A
- Fundamental
- Price
- ACIU $1.98
- ANNA $7.11
- Analyst Decision
- ACIU Strong Buy
- ANNA
- Analyst Count
- ACIU 2
- ANNA 0
- Target Price
- ACIU $12.00
- ANNA N/A
- AVG Volume (30 Days)
- ACIU 197.4K
- ANNA 19.3K
- Earning Date
- ACIU 03-13-2025
- ANNA 05-15-2025
- Dividend Yield
- ACIU N/A
- ANNA N/A
- EPS Growth
- ACIU N/A
- ANNA N/A
- EPS
- ACIU N/A
- ANNA N/A
- Revenue
- ACIU $30,136,397.00
- ANNA $648,328.00
- Revenue This Year
- ACIU $120.91
- ANNA N/A
- Revenue Next Year
- ACIU $13.82
- ANNA N/A
- P/E Ratio
- ACIU N/A
- ANNA N/A
- Revenue Growth
- ACIU 84.51
- ANNA N/A
- 52 Week Low
- ACIU $1.95
- ANNA $4.71
- 52 Week High
- ACIU $4.98
- ANNA $18.70
- Technical
- Relative Strength Index (RSI)
- ACIU 27.05
- ANNA N/A
- Support Level
- ACIU $1.95
- ANNA N/A
- Resistance Level
- ACIU $2.05
- ANNA N/A
- Average True Range (ATR)
- ACIU 0.13
- ANNA 0.00
- MACD
- ACIU -0.02
- ANNA 0.00
- Stochastic Oscillator
- ACIU 6.38
- ANNA 0.00
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About ANNA ALEANNA INC
AleAnna Inc is a developer and producer of natural gas in Italy, engaged in naturally occurring biogenic methane from conventional geological formations and carbon-negative renewable biomethane generated from farm wastes, particularly in the Po Valley of Northern Italy.